Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.

Al-Shaer MH, Alghamdi WA, Alsultan A, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Cegielski JP, Kempker RR, Heysell SK, Peloquin CA.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00279-19. doi: 10.1128/AAC.00279-19. Print 2019 Jul.

2.

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.

Alghamdi WA, Alsultan A, Al-Shaer MH, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Schmidt S, Heysell SK, Kempker RR, Cegielski JP, Peloquin CA.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00055-19. doi: 10.1128/AAC.00055-19. Print 2019 May.

3.

A survey of the tuberculosis physician workforce in the country of Georgia.

Graciaa DS, Machaidze M, Kipiani M, Buziashvili M, Barbakadze K, Avaliani Z, Kempker RR.

Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1286-1292. doi: 10.5588/ijtld.18.0085.

4.

Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia.

Vashakidze L, Salakaia A, Shubladze N, Cynamon M, Barbakadze K, Kikvidze M, Papitashvili L, Nonikashvili M, Solomonia N, Bejanishvili N, Khurtsilava I.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1148-53.

Supplemental Content

Loading ...
Support Center